| Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM ... - CNNMoney.com (press release) |
|
|
CNNMoney.com (press release)New onset or worsening renal impairment occurred in patients who received VIBATIV. Renal adverse events were more likely to occur in patients with baseline ... read more |